Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Not stated
- Not stated
- Not stated
- Not stated
Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.
Or read the full text and all 3 review criteria here, free with an account. Create free account
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related…
Related NIH announcements
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
$200k
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
The full announcement, free with an account
- The full announcement text, not just the first two sentences
- All 3 review criteria reviewers score this against, extracted from this announcement
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
- Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
- A Reviewer Scorecard of your draft against these criteria
More from National Institutes of Health
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Related by subject
Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)
$1.5M
Cooperative Agreement for affiliated Partner with the Rocky Mountain Cooperative Ecosystem Studies Unit
$495k
Cooperative Agreement for affiliated Partner with Rocky Mountain Cooperative Ecosystem Studies Unit
$490k
Hiring in this research area now
- Technology-Driven Integrative Physiology AI-Enabled Cell, Molecular and Genomic Biol Asst/Assoc ProfSalary is commensurate with education and experience.
- Postdoctoral Research ScientistPost-doctoral Research Scientist -- Cancer Research
- Open Rank Faculty (All Levels) in Dept of Oncology ScienceCompetitive